Rockwell Medical, Inc.
RMTI
$1.22
$0.010.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.01% | 96.86% | 94.31% | 86.69% | 58.88% |
| Total Depreciation and Amortization | -0.91% | 18.86% | 50.97% | 108.68% | 252.15% |
| Total Amortization of Deferred Charges | -69.88% | -76.09% | -61.52% | 216.53% | 217.62% |
| Total Other Non-Cash Items | 12.96% | 4.22% | -3.15% | -22.29% | 5.11% |
| Change in Net Operating Assets | 84.31% | 51.62% | 78.92% | 64.48% | -2,616.85% |
| Cash from Operations | 173.87% | 139.10% | 144.65% | 134.74% | 30.69% |
| Capital Expenditure | -67.98% | -236.33% | -255.99% | -102.77% | -13.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -193.40% | -191.33% | -140.16% | -117.21% | 205.61% |
| Cash from Investing | 2.34% | 44.28% | -59.80% | -37.66% | -7.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 61.93% | 64.20% | 65.74% | 64.06% | 62.58% |
| Issuance of Common Stock | -57.91% | -37.61% | -31.49% | -45.57% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -49,900.00% | -41,200.00% | -32,480.00% | -2,081.40% | -- |
| Cash from Financing | -74.40% | -47.44% | -35.21% | -37.48% | 264.01% |
| Foreign Exchange rate Adjustments | 33.33% | -400.00% | -25.00% | 40.00% | 25.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.68% | 211.69% | 696.87% | 187.70% | 113.31% |